Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models
Open Access
- 15 February 2021
- Vol. 10 (2), 399
- https://doi.org/10.3390/cells10020399
Abstract
Chordomas are rare, slow-growing tumors of the axial skeleton. These tumors are locally aggressive and refractory to conventional therapies. Radical surgery and radiation remain the first-line treatments. Despite these aggressive treatments, chordomas often recur and second-line treatment options are limited. The mechanisms underlying chordoma radioresistance remain unknown, although several radioresistant cancer cells have been shown to respond favorably to aldehyde dehydrogenase (ALDH) inhibition. The study of chordoma has been delayed by small patient cohorts and few available models due to the scarcity of these tumors. We thus created cellular 3D models of chordoma by using low-adherence culture systems. Then, we evaluated their radiosensitivity using colony-forming and spheroid size assays. Finally, we determined whether pharmacologically inhibiting ALDH increased their radiosensitivity. We found that 3D cellular models of chordoma (derived from primary, relapse, and metastatic tumors) reproduce the histological and gene expression features of the disease. The metastatic, relapse, and primary spheroids displayed high, medium, and low radioresistance, respectively. Moreover, inhibiting ALDH decreased the radioresistance in all three models.This publication has 49 references indexed in Scilit:
- Descriptive epidemiology of chordomas in the United StatesJournal of Neuro-Oncology, 2020
- The sacral chordoma marginEuropean Journal of Surgical Oncology, 2020
- Chordoma: update on disease, epidemiology, biology and medical therapiesCurrent Opinion in Oncology, 2019
- The driver landscape of sporadic chordomaNature Communications, 2017
- Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyThe Lancet Oncology, 2017
- Chordoma: The Quest for Better Treatment OptionsOncology and Therapy, 2016
- Postoperative Proton Therapy for Chordomas and Chondrosarcomas of the SpineSpine, 2015
- Building a global consensus approach to chordoma: a position paper from the medical and patient communityThe Lancet Oncology, 2015
- Incidence and relative survival of chordomasCancer, 2013
- HISTOCHEMISTRY OF SACROCOCCYGEAL CHORDOMAActa Pathologica Microbiologica Scandinavica Series A :Pathology, 1985